Objective: This study examined sex differences in subacute plasma biomarkers in adolescents post-concussion and their associations with post-concussion symptom (PCS) burden. We hypothesized that biomarker levels would differ by sex and relate to PCS severity. Setting: Participants were recruited from outpatient settings as part of the Concussion Assessment, Research, and Education for Kids (CARE4Kids) multi-site observational study. Participants: Adolescents 11 to 17.99 years with a concussion based on Concussion In Sport Group criteria were eligible. Participants were assessed 7 to 35 days post-injury and required to report at least one PCS exceeding pre-injury baseline. A total of 339 participants (174 females, 145 males) with both blood biomarkers and PCS data were analyzed. Design: Plasma levels of glial fibrillary acidic protein, neurofilament light chain (NFL), ubiquitin C-terminal hydrolase (UCH-L1), tau, and phosphorylated tau at threonine 181 (p-tau181) were measured and compared between sexes. PCS severity was assessed using the Post-Concussion Symptom Inventory, 2nd Ed (PCSI-2) Retrospective Adjusted Post-Injury Difference (RAPID) scoring system. Main Measures: Primary outcomes were sex differences in biomarker levels and their associations with RAPID scores. Results: Females had significantly higher tau (females: M = 6.18, SD = 8.02; males: M = 4.55, SD = 5.53; P = .012) and lower p-tau181/tau ratios (females: M = 6.18, SD = 8.02; males: M = 4.55, SD = 5.53; P = .002) after adjusting for age, BMI, and days post-injury. In both sexes, cognitive symptoms were associated with higher p-tau181. In females, emotional symptoms were associated with elevated NFL and UCH-L1. In males, physical and overall symptoms were associated with lower NFL, UCH-L1, and p-tau181. Conclusion: This study highlights sex-specific biomarker differences during adolescent concussion recovery and the importance of understanding how sex differences may influence symptom burden and recovery trajectories. Future research should examine hormonal influences on biomarker profiles and prolonged symptomatology.
This study identifies a significant association among blood-based biomarkers of traumatic brain injury (TBI) and the Marshall CT classification of TBI (MCTC) scores, but not with Glasgow Coma Scale (GCS) scores. We aimed to determine whether GCS and MCTC scores relate to glial fibrillary acid protein (GFAP), ubiquitin carboxy hydrolase-1 (UCH-L1), tau, neurofilament light chain (NfL), and phosphorylated tau (p-tau231) concentrations following acute TBIs. Participants included patients from 20 trauma centers across 12 regional sites in the United States and Canada with an initial CT scan within 6 h after TBI and GCS scores of 3 to 12. Blood samples collected upon hospital arrival were analyzed for biomarker concentrations (pg/mL). Concentrations from 271 patients with GCS ≥ 9 were compared to 145 with GCS ≤ 9. Samples from 347 patients with MCTC < 3 were compared to 70 with MCTC ≥ 3. No significant differences in GCS groups were found (p’s > 0.5), while MCTC groups differed significantly (p’s < 0.001). Higher concentrations of plasma GFAP, NfL, and p-tau231 correlated with MCTC scores > 3, with no associations with GCS. Future research might show an application in individual risk assessments to improve triaging of TBI patients.